Sangamo BioSciences Cash and ST Investments:
63.55M for Dec. 31, 2012Sangamo BioSciences Historical Cash and ST Investments Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 63.55M |
| Sept. 30, 2012 | 57.90M |
| June 30, 2012 | 59.64M |
| March 31, 2012 | 79.70M |
| Dec. 31, 2011 | 84.13M |
| Sept. 30, 2011 | 84.45M |
| June 30, 2011 | 91.49M |
| March 31, 2011 | 45.75M |
| Dec. 31, 2010 | 60.28M |
| Sept. 30, 2010 | 62.74M |
| June 30, 2010 | 68.99M |
| March 31, 2010 | 76.54M |
| Dec. 31, 2009 | 84.94M |
| Sept. 30, 2009 | 47.69M |
| June 30, 2009 | 52.26M |
| March 31, 2009 | 57.70M |
| Dec. 31, 2008 | 64.83M |
| Sept. 30, 2008 | 59.24M |
| June 30, 2008 | 64.05M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
Learn More
SGMO Cash and ST Investments Benchmarks
| Companies | |
|---|---|
| Exact Sciences Corporation | 95.48M |
| Isis Pharmaceuticals | 416.77M |
| Achillion Pharmaceuticals | 144.99M |
SGMO Cash and ST Investments Rankings
| Overall |
71st percentile 2180 of 7593 |
| Sector |
62nd percentile 243 of 650 in Healthcare |
| Industry |
62nd percentile 88 of 237 in Biotechnology |
SGMO Cash and ST Investments Range, Past 5 Years
| Minimum | 45.75M | Mar 2011 |
| Maximum | 91.49M | Jun 2011 |
| Average | 66.62M |
